MedPath

Effects of Xuebijing on degradation of vascular endothelial glycocalyx in patients with sepsis

Phase 1
Recruiting
Conditions
sepsis
Registration Number
ITMCTR2000004169
Lead Sponsor
Affiliated Hospital of Nantong University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Hospitalized patients with sepsis or even septic shock admitted to our EICU and emergency internal medicine ward refer to the 2016 international guidelines for the management of sepsis and septic shock.

Exclusion Criteria

1.Aged < 18 years.
2.Death within 24 hours after admission to EICU.
3.Obvious bleeding tendency on admission.
4.Patients who have been combined with similar preparations of Xuebijing.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Syndecan-1;Hyaluronan;Heparan Sulfate;
Secondary Outcome Measures
NameTimeMethod
APACHE?;Length of ICU stay;
© Copyright 2025. All Rights Reserved by MedPath